title: Progressive optic nerve collateralization after serial intravitreal ranibizumab injections for central retinal vein occlusion.
authors.affiliation: Vitreous-Retina-Macula Consultants of New York, New York, New York, USA.
authors.forename: Naomi
authors.initials: N
authors.lastname: Goldberg
authors.forename: K Bailey
authors.initials: KB
authors.lastname: Freund
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000209:etiology*; D009898:Optic Disk / Q000098:blood supply*; D000069579:Ranibizumab; D012170:Retinal Vein Occlusion / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab